Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 7,853 followers.

RT @J_AlbertBarbera: Great work led by Isabel Blanco @isabelclinic. Proud to be part of it.

RT @PPVessels: Great collaboration with @isabelclinic and @J_AlbertBarbera ⬇️⬇️⬇️

RT @J_AlbertBarbera: Great work led by Isabel Blanco @isabelclinic. Proud to be part of it.

Great collaboration with @isabelclinic and @J_AlbertBarbera ⬇️⬇️⬇️

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.